Vitamin D levels of anaesthetists in the department of anaesthesiology at the University of the Witwatersrand by Kelly, Eugene Hamerton
Vitamin D levels of anaesthetists in the
Department of Anaesthesiology at the
University of the Witwatersrand
Eugene Hamerton Kelly
A research report submitted to the Faculty of Health Sciences,
University of the Witwatersrand, Johannesburg, in partial
fulfilment of the requirements for the degree
of
Master of Medicine in the branch of Anaesthesiology
Johannesburg, 2016
i
Declaration 
I, Eugene Hamerton Kelly, declare that this research report is my own work. It is 
being submitted for the degree of Master of Medicine in the branch of 
Anaesthesiology in the University of the Witwatersrand, Johannesburg. It has not 
been submitted before for any degree or examination at this or any other University. 
.............................. (Signature) 
.............................. day of .............................., 20..........
ii
Abstract 
Background and Objective 
There has been a recent resurgence of interest in vitamin D and its far-reaching 
effects in physiology and pathophysiology. Theatre personnel, and all indoor 
workers, should be cognisant of vitamin D deficiency as a real occupational hazard. 
Vitamin D deficiency is a global problem that has been studied extensively in colder 
climates and even been found in warmer climates. No research was identified 
among medical personnel in South Africa.
The primary objective of this study was to describe serum 25-hydroxyvitamin D 
(25(OH)D) levels of anaesthetists.
The secondary objective was to describe and compare factors influencing vitamin D 
levels in anaesthetists who are vitamin D insufficient to those who are not. These 
factors included: ethnicity, gender, body mass index (BMI), multivitamin use, calcium 
or vitamin D supplementation, sun exposure, vitamin D intake from diet alone, 
vitamin D intake from diet and supplementation and calcium intake (dairy).
Methods 
Data was collected over a period of one month, in winter (mid-July to mid-August 
2013).
On the morning of sample collection anaesthetists agreeing to participate signed the 
informed consent (Appendix 2), prior to enrolment in the study. The anaesthetists 
then completed the questionnaire (Appendix 5). The following data was obtained 
from the questionnaire: age, gender, ethnic group, dietary supplementation, sun 
exposure, sunscreen use, BMI and diet.
Each participant had 5 ml of blood collected in a standardised manner into a purple 
top ethylenediaminetetraacetic acid blood specimen tube. The processing of 
samples was done by qualified laboratory personnel using standard chemical 
pathology equipment and procedures. High Performance Liquid Chromatography 
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was performed to determine 25(OH)D levels using a Shimadzu® Nexera X2 Ultra 
performance liquid chromatography system with a photodiode array detector 
(Shimadzu®, Japan).
Results 
The median 25(OH)D was 43.8 nmol/l (IQR 26-76), with 51 of 89 (57.30 %) 
anaesthetists being vitamin D insufficient.
There was a statistically significant association between ethnicity and vitamin D 
status (p<0.001). Twenty-one (80.77 %) Indian anaesthetists and 14 (70.00 %) black 
anaesthetists were vitamin D insufficient, as compared to only 10 (28.57%) white 
anaesthetists.
There was no significant association between the other secondary objectives-gender
(p=0.60), sun exposure (p = 0.93), vitamin D intake from diet alone (p= 0.07), vitamin
D intake from diet and supplementation (p=0.05) and calcium intake (p=0.55) and 
vitamin D status.
There was no significant difference between BMI and vitamin D status. When a 
comparison was made between the two groups of BMI <25 and BMI ≥25, using a 
Mann-Whitney test the two-tailed P value was 0.6791. There was a significant 
association between multivitamin use (p=0.01) and vitamin D status.
Conclusion 
Vitamin D should no longer be a forgotten vitamin. The insufficient vitamin D levels of
anaesthetist in this study, puts them at risk for pathology far beyond bone health.  
Adequate vitamin D levels should be seen as essential, rather than optional, even in 
“sunny” climates. 
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Chapter 1 Overview
1.1 Introduction
This chapter presents the background to the problem, problem statement, aim and 
objectives and research assumptions. Demarcation of the study field, ethical 
considerations, research methodology, significance of the study and validity and 
reliability are summarised. The study outline is also presented. 
1.2 Background
There has been a recent resurgence of interest in vitamin D and its far-reaching 
effects in physiology and pathophysiology (1, 2). Theatre personnel, and all indoor 
workers, should be cognisant of vitamin D deficiency as a real occupational hazard.
Sun exposure is a major source of vitamin D in most people. The ultraviolet B (UVB) 
rays cause the conversion of 7-dehydrocholesterol in the skin to previtamin D3, which
eventually isomerizes to vitamin D3. Sunscreens absorb UVB photons, reducing 
vitamin D synthesis by as much as 92-95% in the case of Factor 8 sunscreen (3). 
Melanin does the same, hence it significantly affects vitamin D levels (4). 
Vitamin D produced in the skin has a half-life of at least twice that of orally ingested 
vitamin D (5). According to the Institute of Medicine (IOM) Guidelines the 
recommended daily allowance (RDA) of vitamin D for a 19 to 50 year old male or 
female is 600 IU. Sitting in the sun is a more convenient alternative to attain this 
RDA, as 5 to 10 minutes of sun exposure to the arms and legs produces about     
3000 IU vitamin D, versus the average multivitamin tablet that contains only 400 IU. 
(1, 6) Dietary sources of vitamin D are limited, unless foods are specifically fortified 
(1).
Vitamin D deficiency may not only interfere with one’s attainment of peak bone mass,
but has numerous previously unrecognised effects which include immune modulation
(7, 8), increased risk of certain cancers, autoimmune conditions, cardiovascular 
disease and mental illness (1, 9).
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It is estimated that worldwide, there are one billion people who are vitamin D 
deficient (1, 10). In colder climates, people have been more aware of insufficient sun 
exposure leading to vitamin D deficiency. This is especially true amongst “at risk” 
populations, like the elderly in Europe, where mean vitamin D levels have been 
found to be in the deficient range (11). Doctors have only more recently been 
studied, and were found to have a high prevalence of deficiency. Amongst Boston, 
Massachusetts trainee doctors, 25% were deficient (12). In Portland, Oregon, the 
prevalence of deficiency was as high as 47% among resident doctors (13). 
Studies in warmer climates found vitamin D deficiency to be even more common at 
times. Amongst a cohort of healthy Saudi Arabian men, 87% were found to be 
deficient of vitamin D (14). A study in Mexico, among resident doctors found a 
prevalence of deficiency of 75% (15).
This brings to light the multiple factors influencing vitamin D levels. These range from
cultural norms to dietary supplementation and milk fortification. (16) Review of 
current literature revealed a paucity of data on vitamin D levels in adult South 
Africans. In addition, no research could be identified among medical personnel in 
South Africa. 
1.3 Problem statement
Anaesthetists are indoors for most of their work hours and thus are at risk for vitamin
D deficiency. Vitamin D is critical for calcium homeostasis and deficiency will hinder 
one’s attainment of peak bone mass (1). The other effects of vitamin D deficiency are
less obvious, but still widespread in physiology, affecting immunity (7, 8), increasing 
risk of certain cancers, autoimmune conditions, cardiovascular disease and mental 
illness (1, 9).
Vitamin D deficiency is a global problem (1, 10, 17) that has been studied 
extensively in colder climates (9, 12, 13) and even been found in warmer climates 
(14, 15, 18). No research was identified among medical personnel in South Africa. In 
the Department of Anaesthesiology, University of the Witwatersrand (Wits), 
anaesthetists work on average 48 hours a week. All of these hours are spent indoors
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and even though some are evening shifts, many daytime hours are spent doing 
preoperative visits, attending tutorials or studying. For these reasons the study 
population is at risk for vitamin D deficiency, despite South Africa commonly being 
thought of as a land of sunshine (19). 
1.4 Aim and objectives
1.4.1 Aim
The aim of this study was to describe serum 25-hydroxyvitamin D [25(OH)D] levels 
during winter (mid-July to mid-August 2013), in anaesthetists working in the 
Department of Anaesthesiology, Wits.
1.4.2 Objectives
The primary objective of this study was to describe serum 25(OH)D of anaesthetists.
The secondary objective was to describe and compare factors influencing vitamin D 
levels in anaesthetists who are vitamin D insufficient to those who are not. These 
factors included:
 ethnicity
 gender
 body mass index (BMI)
 multivitamin use
 calcium or vitamin D supplementation 
 sun exposure
 vitamin D intake from diet alone
 vitamin D intake from diet and supplementation
 calcium intake (dairy).
1.5 Research assumptions
The following definitions were used in this study.
Anaesthetist: in this study referred to a registrar or medical officer working in the 
Department of Anaesthesiology.
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Medical Officer: a doctor employed by the provincial government in a medical 
officer position in the Department of Anaesthesiology.
Registrar: a doctor that is in the process of obtaining a specialist anaesthesiology 
qualification, endorsed by the Health Professions Council of South Africa.
Ethnic groups are defined below.
 Arab- person of Arabic descent. 
 Asian- a non-Indian person of Asian descent.
 Black- black people of African descent.
 White- Caucasian or of European descent.
 Indian- Asian-Indians with ancestry from India.
 Coloured- a person of mixed origin who possesses ancestry from Europe, 
Asia and Black ethnic groups.
25(OH)D: serum 25-hydroxyvitamin D. This is the major circulating form of vitamin D 
and the form which is measured in the laboratory (6). In this study serum 25-
hydroxyvitamin D will be referred to as 25(OH)D.
Calcitriol: physiologically active hormone- 1,25-dihydroxyvitamin D.
According to the IOM, vitamin D status in free living healthy adults, with regard to 
bone health is defined as: 
 vitamin D deficiency: 25(OH)D < 30 nmol/l (<12 ng/ml) (6)
 vitamin D inadequacy: 25(OH)D of 30 to 50 nmol/l (12 to 20 ng/ml will be 
considered insufficient (6)
 vitamin D sufficiency: 25(OH)D > 50 nmol/l (>20 ng/ml) will be considered 
sufficient (6).
Most of the studies in doctors that were reviewed, combine the vitamin D deficient 
and inadequate categories into one (12, 13, 15, 20). For this study this group will be 
called “vitamin D insufficient”. 
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The unit of measurement used by the IOM is ng/ml. The National Health Laboratory 
Service that was used for this study uses nmol/l as the unit of measurement. The 
conversion factor for ng/ml to nmol/l is 2.5 (2.496).
1.6 Demarcation of study field
This study was conducted in the Department of Anaesthesiology, Wits. The Wits 
Medical School is associated with: Chris Hani Baragwanath Academic Hospital 
(CHBAH), Charlotte Maxeke Johannesburg Academic Hospital (CMJAH), Helen 
Joseph Hospital (HJH) and Rahima Moosa Mother and Child  Hospital (RMMCH).
 
1.7 Ethical considerations
Appropriate approvals from the relevant authorities were obtained.
The study was conducted adhering to strict ethical considerations.
The study was conducted according to the principles of the Declaration of Helsinki 
(21) and the South African Good Clinical Practice Guidelines and Good Laboratory 
Practice Guideline (22).
1.8 Research methodology
1.8.1 Research design
This study used a prospective, contextual, descriptive research design.
1.8.2 Study population
The study population was anaesthetists working in the Department of 
Anaesthesiology. 
1.8.3 Study sample
In consultation with a biostatistician a sample size of 81 anaesthetists was calculated
with nQuery Advisor® version 7. A convenience sampling method was used.
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1.8.4 Inclusion and exclusion criteria
Specific inclusion and exclusion criteria for the study were defined.
Inclusion criteria for this study are listed below.
 Anaesthetists in the Department of Anaesthesiology at Wits.
 Consenting to take part in the study.
1.8.5 Data collection
Data was collected over a period of one month, in winter (mid-July to mid-August 
2013).
The specimen taking, labelling, storage and transport and processing were done in a
standardised manner.
1.8.6 Data analysis
Data was captured on Microsoft Office Excel 2010® spread sheets and analysed with
the assistance of a biostatistician using Statistica® Version 12.5.
1.9 Significance of the study
Vitamin D deficiency is a global health problem, with an estimated 1 billion people 
deficient worldwide (1, 10). Deficiency has far-reaching effects in normal physiology 
and pathophysiology (1, 2) such as interference with one’s attainment of peak bone 
mass, immune modulation (7), increased risk of certain cancers, autoimmune 
conditions, cardiovascular disease and mental illness (1).
If vitamin D deficiency and inadequacy were found to be prevalent amongst 
anaesthetists in the Department of Anaesthesiology, this may further highlight the 
magnitude of vitamin D insufficiency in sunny climates. Furthermore, actions could 
be taken to rectify the insufficiency, thereby contributing to the anaesthetists’  well-
being.
1.10 Validity and reliability of the study
Measures were taken to ensure the validity and reliability of the study.
6
1.11 Study outline
This study will be presented as follows:
 Chapter 1 – Overview of study
 Chapter 2 – Literature review
 Chapter 3 – Research methodology
 Chapter 4 – Results and discussion
 Chapter 5 – Limitations, recommendations and conclusion.
Summary
In this chapter the background to the problem, problem statement, aim and 
objectives and research assumptions as well as the demarcation of the study field, 
ethical considerations, research methodology, significance of the study and validity 
and reliability were summarised. The study outline was also presented. 
The literature review is presented in the following chapter.
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Chapter 2 Literature Review
2.1 Introduction
This literature review will address the physiology of vitamin D. It will then explore the 
epidemiology of vitamin D deficiency, the factors influencing vitamin D levels, the 
laboratory testing of vitamin D and then discuss the health consequences of vitamin 
D deficiency.
2.2 Vitamin D physiology
Vitamin D, also known as calciferol, is a fat-soluble vitamin that occurs in two major 
forms:  vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Vitamin D2 is the 
main form manufactured for supplementation or to fortify food. Sun exposure 
supplies  50 to 90% of vitamin D in the body, through synthesis of vitamin D3  in the 
skin (17). Vitamin D3 can also be made commercially, although less commonly than 
vitamin D2 (6).
The only difference between the two molecules is the structure of their side chains. 
This does not interfere with their effectiveness, as evidenced by the ability of both to 
treat vitamin D-deficient rickets. (23)
The following aspects of vitamin D will be briefly discussed: cutaneous vitamin D3  
synthesis, vitamin D metabolism and vitamin D’s role in homeostasis. 
2.2.1 Cutaneous vitamin D3  synthesis
Through a process known as thermal isomerization, UVB rays from the sun result in 
conversion of 7-dehydrocholesterol in the skin to previtamin D3. This molecule then 
isomerizes to vitamin D3. Vitamin D production in the skin is dependent on the 
amount of UVB photons reaching the dermis, as well as the amount of 7-
dehydrocholesterol in the skin. The absorption of UVB radiation is affected by 
season, latitude, clothing, sunscreen and skin melanin content. Age affects 7-
dehydrocholesterol levels negatively. (1)
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Ultraviolet (UV) radiation is quantified using the minimal erythemal dose (MED) as a 
unit of comparison. One MED is defined as an adult wearing a bathing suit exposed 
to enough UV radiation to cause a slight pinkness of the skin 24 hours after 
exposure. This results in a vitamin D production equivalent to ingesting between 
10,000 and 25,000 IU of vitamin D. (16) Exposure of arms and legs to sunlight 
between 10:00 and 15:00 for an average of 5 to 10 minutes, produces about 3000 IU
vitamin D and is equivalent to 0.5 MED (1).
2.2.2 Vitamin D absorption
Vitamin D, being a fat-soluble vitamin, is absorbed with other fats from the diet in the 
small intestine (5). The absorption depends on the fat concentration in the intestinal 
lumen, which triggers bile acid and pancreatic lipase release. The bile acids emulsify
lipids, while the pancreatic lipase hydrolyses triglycerides into monoglycerides and 
free fatty acids. The importance of bile acid and pancreatic lipase has been revealed 
by the significant reduction in vitamin D absorption in people with compromised bile 
release or pancreatic insufficiency. (6)
Vitamin D is bundled in the intestinal wall with other lipids, cholesterol, triglycerides 
and lipoproteins into chylomicrons. These chylomicrons reach the systemic 
circulation via the lymphatic circulation. (6)
2.2.3 Vitamin D activation 
Dietary vitamin D2 and D3, as well as vitamin D3 synthesized in the skin, all require 
activation via two enzymatic hydroxylation reactions. The first of these is catalysed 
by 25-hydroxylase in the liver to form 25-hydroxyvitamin D. (24) The second reaction
takes place in the kidney, whereby 1α-hydroxylase converts 25-hydroxyvitamin D to 
the physiologically active hormone 1,25-dihydroxyvitamin D (calcitriol). This reaction 
is accelerated by parathryroid hormone (PTH) and retarded by fibroblast-like growth 
factor-23. (6) The significance of the fact that this last reaction is able to take place in
organs other than the kidney, which also contain the 1α-hydroxylase enzyme, may lie
in vitamin D’s antiproliferative role in some cancers (1). 
The major circulating form of vitamin D is 25(OH)D. In the blood it is bound to a 
specific carrier protein, vitamin D binding protein. (6, 25)
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2.2.4 Vitamin D excretion
Metabolic destruction of vitamin D is catalysed by 24-hydroxylase. The by-products 
are excreted through bile into the faeces. Minimal amounts are excreted in the urine. 
(26)
The average lifetime of vitamin D in the body is about two months. 25(OH)D, 
remains in the body for about 15 days, whereas the active form, calcitriol has a 
lifetime of a few hours only (26). For this reason, laboratory measurement is usually 
of 25(OH)D.
2.2.5 Actions of vitamin D: role in calcium homeostasis
Calcium homeostasis is orchestrated predominantly by the vitamin D, PTH endocrine
system. The main objective of this negative feedback system is to achieve optimal 
levels of ionized calcium in the blood. (24)
Calcium is the main electrolyte in bone, which contains more than 99% of total body 
calcium as calcium hydroxyapatite. Its effects are ubiquitous in human physiology as 
a second messenger. It also plays an integral role in extracellular fluid, muscle 
function, vasodilation and vasoconstriction, coagulation, as well as hormonal 
secretion. (24)
During periods of hypocalcaemia, calcium can rapidly be mobilised from bone. This 
begins with the calcium sensing receptor in the parathyroid gland detecting 
insufficient ionized calcium levels in the serum and triggering PTH release. The PTH 
then induces 1α-hydroxylase activity in the kidney to convert 25(OH)D to 1,25(OH)D.
Calcitriol, in turn, provides negative feedback, decreasing further PTH release. (25)
Calcitriol stimulates intestinal calcium absorption, bone resorption and also 
stimulates the kidneys to reabsorb more calcium and phosphorous. (25)
There are two mechanisms of calcium absorption: active (transcellular) transport and
passive (paracellular) diffusion across intestinal mucosa. (6) The former mechanism 
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is dependent on the interaction between calcitriol and the intestinal vitamin D 
receptor (VDR). During low and moderate calcium intake, absorption takes place via 
this mechanism. The VDR can be upregulated via genetic mechanisms during 
periods of deficiency. This receptor has the highest concentration in the duodenum. 
(27)
Passive diffusion is paracellular and as in other types of diffusion is dependent on a 
concentration gradient. As a result of this, diffusion takes place more commonly 
during periods of high calcium intake, which results in high intestinal calcium 
concentrations. Diffusion is also less selective than active transport and occurs 
throughout the small intestine. (28)
2.2.6 Non calcium effects of vitamin D
Vitamin D-responsive elements are an integral component of vitamin D’s non-
calcium effects. They are present in many human genes with effects ranging from 
regulating cell proliferation, differentiation and apoptosis to immunomodulatory 
effects (8). It is these effects that are thought possibly to play a role in cancer (29) 
and chronic conditions of infective, auto-immune and cardiovascular origin (1).
2.3 Vitamin D deficiency
2.3.1 Definition 
There is controversy in the literature with regard to the level of 25(OH)D that is 
deemed deficient, inadequate and sufficient. The IOM definitions are for free living 
healthy adults. It is incorrect to use these definitions for populations that are at risk 
for vitamin D deficiency. Thus the definitions of the Endocrine Society would be more
appropriate for these populations specifically.(16) 
The definitions according to the IOM will be used for this study and were defined in 
Chapter 1 in the research assumptions. 
2.3.2 Epidemiology
It is estimated that, according to the above definitions, 1 billion people worldwide 
have vitamin D deficiency or insufficiency, with very few regions excluded (1, 10). 
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When looking at the global prevalence of vitamin D deficiency or insufficiency, the 
numerous factors influencing its complexity come to light. The epidemiology and 
most important factors influencing vitamin D levels will be briefly discussed.
North America
Some of the most extensive epidemiological data regarding vitamin D status in the 
United States of America (USA) may be obtained from the National Health and 
Nutrition Examination Survey (NHANES) in the USA. This survey is conducted by 
the National Center for Health Statistics and the Centers for Disease Control and 
Prevention. Its aim is to assess the health and nutritional status, utilizing a 
representative sample of 20 289 non-institutionalised, civilian people. This survey 
takes place every four to six years and although it only pertains to the USA, it is very 
extensive, with sampling accounting for differences in latitude, seasonal variation 
and race. (30)
The NHANES 2000-2004 revealed the following: age standardised mean serum 
25(OH)D was 65 nmol/l in non-hispanic whites (vitamin D sufficient) and 40 nmol/l 
(vitamin D insufficient) in non-hispanic blacks. Values were slightly lower in women 
than men. (30)  
Looker et al. (30) identified three factors that negatively affected serum 25(OH)D. 
These were low milk intake, use of sun protection and BMI. The reason for this 
relationship is likely to be the fact that numerous foods in the USA are fortified with 
vitamin D. These include margarine, cereals, orange juice and milk. (9, 17)
The most recent analysis of the NHANES 2005-2006 data identified was by Forrest 
et al. (31). It showed an overall prevalence of vitamin D insufficiency of 41.6%, with 
the highest rate in black individuals (82.1%) and hispanics (69.2%). 
Latin America
In the review by Lips et al. (17) on worldwide vitamin D nutrition, the following 
conclusion is drawn: “data on vitamin D status in Latin America are scarce and 
population studies are not available.” A prior study by Lips et al. (32) amongst 
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osteoporotic postmenopausal women showed a mean serum 25(OH)D of 65 nmol/l 
in Mexico, 81 nmol/l in Brazil and 75 nmol/l in Chile. In comparison to similar 
populations in North America the vitamin D status is better. Using IOM definitions 
none of these is considered insufficient, however this is in a population at risk for 
vitamin D deficiency and thus the definitions of deficiency of the Endocrine Society 
would be more appropriate.(16) 
Maeda et al. (33) studied vitamin D levels in healthy hospital workers in Brazil and 
also found reasonable vitamin D status. Resident doctors had mean 25(OH)D levels 
of 67 nmol/l (sufficient) and hospital workers and medical students had even higher 
levels (33).
Europe
Europe shows great diversity with regard to vitamin D levels. Some studies found 
severe deficiency (25(OH)D below 25 nmol/l) in 2 to 30% of adults. The prevalence 
increased to 75% or more in elderly, institutionalised people. (10) The European 
Action on Nutrition and Health-Survey was a multicentre study in 12 European 
countries. Overall, it showed that 36% of men and 47% of women had serum 
25(OH)D levels of less than 30 nmol/l, with mean serum 25(OH)D levels of 20 to 30 
nmol/l in Southern European centres and 40 to 50 nmol/l in Northern European 
centres. The reason for the difference between north and south was the high intake 
of fatty fish and cod liver oil in Northern Europe, despite lower UVB radiation at the 
higher latitude. (10, 11)
By IOM definitions the above European figures all fall into the vitamin D insufficient 
category. A compounding factor could be the advanced age of most of the study 
participants, with the average age in the European Action on Nutrition and Health-
Survey trial being older than 70 years.
Asia
Mithal et al. (10) in their review, concluded that in South Asia there was widespread 
vitamin D deficiency, in both sexes and across all age groups. The factors influencing
levels in Asia were hypothesised to be darker skin pigmentation, traditional clothing 
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and minimal outdoor activity. Air pollution as an additional factor amongst urban 
people was also elucidated (34). 
Numerous studies across India have indicated a high prevalence of deficiency. A 
study based in Delhi, found the prevalence of vitamin D deficiency to be 90% in 
otherwise healthy school girls, across socioeconomic groups (35). Arya et al. (36) 
performed a study amongst healthy hospital staff members in Lucknow, India, and 
the prevalence of deficiency was 78%. Darker skin pigmentation and decreased sun 
exposure due to cultural attire were likely factors influencing the levels (36).
Middle East
The Middle East has been found to have rates of vitamin D deficiency as high as 
87%, despite the sunny climate (14). In the study by Ardawi et al. (14), healthy Saudi 
Arabian men across all age groups were found to be deficient. Severe vitamin D 
deficiency (< 24.96 nmol/l) was most commonly seen in “at risk” populations like the 
elderly (10). 
Contributing factors are decreased sun exposure due to cultural clothing, prolonged 
periods of breastfeeding, darker skin pigmentation and calcium deficiency (37). 
Amongst Turkish women, cultural clothing’s role was clearly delineated. Turkish 
women who wore a veil had a mean serum 25(OH)D of 32 nmol/l, while those who 
were completely covered had a mean of only 9 nmol/l. Turkish women who wore 
western clothing had a mean serum 25(OH)D of 56 nmol/l. (17) 
Oceania
Literature from Australia and New Zealand has recently earmarked vitamin D 
deficiency as a significant healthcare problem. Seasonal variation as a compounding
factor is an underlying theme, as well as geographical latitude, advanced age and 
genetic influence. (38, 39) Genetic influence has been noticed in many immigrant 
and indigenous people. This may be as a result of increased skin pigmentation or 
cultural avoidance of sun exposure, as opposed to actual genetic influence on 
vitamin D levels. (10) Sunscreen use would be expected to decrease vitamin D 
levels, however, when this was studied in Australia, no effect was seen across all 
age groups (40). 
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Van der Mei et al. (39) compared data from cross-sectional studies of three regions 
across Australia: southeast Queensland (27°S), Geelong region (38°S), and 
Tasmania (43°S). They found that the prevalence of vitamin D deficiency was 40.5% 
in southeast Queensland, 37.4% in the Geelong region, and 67.3% in Tasmania. 
They concluded that vitamin D insufficiency is prevalent over a wide geographical 
latitude range. They also found season to play more of a role than latitude. They 
emphasised the importance of behavioural factors, as season and latitude did not 
sufficiently account for the variation in serum 25(OH)D levels. (39)
Africa
In the review by Prentice et al. (41) it was concluded that studies in Africa have an 
important geographical gradient with regard to 25(OH)D levels. These range from 
deficiency in North African countries to high values in equatorial countries. Seasonal 
variation in sun exposure is only of significance outside the tropics (30˚N and 30˚S). 
Thus in countries like Morocco, Tunisia, Algeria, Libya, Egypt and South Africa, 
dietary sources of vitamin D are essential to prevent deficiency during winter. (41)
The central themes with regard to the factors influencing vitamin D levels in Africa 
are the following.
 40% of Africa follow the Islamic faith, thus religious attire influences sun 
exposure (41).
 Low calcium intake (42) and the burden of infectious disease increase vitamin
D utilization and turnover (41).
 Rates of malnutrition in Africa are the highest in the world (43) and this is 
commonly associated with vitamin D and calcium deficiency .
 In Africa dietary vitamin D intake is low and absorption is further hindered by 
the high prevalence of tropical enteropathy (41, 44).
South Africa
Most of the studies in South Africa have been done in children and women. Serum 
25(OH)D levels ranged from deficient, in a few children studied with active rickets, to 
sufficient levels in the rest. Possible factors contributing to deficiency include skin 
pigmentation and low dietary calcium. (45-47)
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In the study by Daniels et al. (48) in South African women, premenopausal black 
women had a mean serum 25(OH)D of 48.3 nmol/l; premenopausal white women 
65.8 nmol/l; postmenopausal black women 47.5 nmol/l and postmenopausal white 
64.5 nmol/l. The black women in this study were vitamin D insufficient and the white 
women sufficient. There was no difference in levels between pre and 
postmenopausal women. The reasons were not elucidated (48)
In a study by Pettifor et al. (49), among 232 elderly black women with femur neck 
fractures, mean serum 25(OH)D was found to be 44.3 nmol/l, with a significant 
seasonal variation. Van Papendorp (50) also showed that elderly nursing home 
residents in South Africa had a mean serum 25(OH)D of 32 nmol/l, thus being 
insufficient.
Using IOM definitions here would also lead to inaccuracies as these are for free 
living healthy adults. Most of these populations studied are at risk for vitamin D 
deficiency and thus the definitions of deficiency of the Endocrine Society would also 
be more appropriate.(16)
A recent study by George et al. (51) in healthy urban African and Asian-Indian adults 
revealed a prevalence of vitamin D deficiency of 28.6% in Asian-Indian subjects as 
opposed to just over 5% in African individuals.
Doctors
Studies among doctors are summarised in Table 2.1.  The study sample and mean 
25(OH)D in nmol/l and ng/ml are given. The percentage of the population that was 
insufficient, geographical location, season and study population are illustrated. The 
U.V index during the period in which the studies were conducted is also included. 
The U.V index will be discussed as a factor influencing sun exposure in the following 
section.
Study Sample
size
Mean 
25(OH)D
nmol/l
Mean 
25(OH)D
ng/ml
Vitamin D
Insufficient
(%)
Location Season
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Growdon (12) 102 67±26 26.84±10.41 25
Boston, 
USA Winter
Tangpricha (20) 165 74.88±24.96 30±10 30
Boston, 
USA End winter
Tangpricha (20) 142 87.36±24.96 35±10 11
Boston, 
USA End summer
Haney (13) 35 50.92±18.97 20.4±7.6 47
Portland 
Oregon, 
USA
Spring (End 
winter)
Haney (13) 35 61.65±19.97 24.7±8.0 26
Portland 
Oregon, 
USA
Fall (End 
summer)
Mendoza (15) 20 42.18±12.73 16.9±5.1 75
Mexico 
City, 
Mexico Summer
Table 2.1 Summary of studies amongst doctors
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2.4 Factors affecting 25(OH)D levels
Studying the factors responsible for fluctuating vitamin D levels is essential to 
understand and combat the problem. Many of the factors have been named in the 
section on epidemiology, but further discussion will follow below.
The factors influencing vitamin D supply can be separated into three broad 
categories:
 dietary intake: diet, food fortification, supplementation  
 sun exposure: geographical location, time of exposure, season, clothing, skin 
pigmentation and sunscreen use
 inadequate cutaneous synthesis, absorption and metabolism: age, BMI, fat 
malabsorption syndromes and medication use. 
Finally, increased vitamin D turnover and utilization may also decrease vitamin D 
levels. This may result from inadequate calcium intake (42) or happen as a result of 
chronic disease (41).
2.4.1 Dietary intake
The two main sources of vitamin D are food and dietary supplements. Very few foods
are naturally high in vitamin D. Foods that contain ample vitamin D are egg yolk, fish 
liver oil and oily fish (eg: sardines, herring, anchovies, salmon, trout and mackerel). 
Vitamin D fortification of certain foods also takes place, for example in the USA milk 
is fortified with 385 IU per litre. (9) Some cereals, orange juice, yoghurts and 
margarine are also fortified in the USA. In most European countries milk is not 
fortified, however, margarine and some cereals are. (9) 
In South Africa very few foods are fortified with vitamin D, limited almost only to 
certain margarines. These are fortified with between 22.5 and 50 IU of vitamin D per 
5 g serving. The reason for this limited fortification is most probably due to the fact 
that 25(OH)D levels of most South Africans are assumed to be adequate. An 
average South African diet, much like the rest of Africa, has minimal vitamin D but 
due to ample sunshine vitamin D deficiency is relatively uncommon. (41, 54)
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The IOM (6) and The Endocrine Society (16) conclude that where sun exposure is 
inadequate, dietary supplements are the only way to ensure adequate vitamin D 
levels. Quantities needed for repletion of stores are higher than the usual RDA (6). 
Most people however, have unpredictable dietary intake of vitamin D rich foods (39). 
Inadequate calcium intake has also been found to decrease serum 25(OH)D levels, 
hence calcium supplementation may alleviate the problem even further. (37, 47)
As with all medication, supplementation is limited by the compliance of the patient. 
Elderly patients, who are most at risk for deficiency, are often the least compliant, 
likely due to the number of medications already being taken (55).
According to The Endocrine Society Clinical Guideline and the IOM, the RDA of 
vitamin D for a  19 to 50 year old male or female is 600 IU (15 μg). However, for 
patients at risk for vitamin D deficiency 1500-2000 IU is recommended as a daily 
requirement. (6, 16) If an average multivitamin contains 400-1000 IU and 100 g of 
salmon contains 100 -250 IU (1), it is clear that anyone at risk for deficiency needs to
specifically quantify their vitamin D intake and ensure that it is adequate. It is also 
clear why sun exposure is such an attractive alternative, as 5 to 10 minutes of sun 
exposure to the arms and legs produces about 3000IU vitamin D with no risk of 
overdose (1, 6).
Overdosing vitamin D can result in toxicity (hypercalcaemia and 
hyperphosphataemia), however it is very rare as extremely high doses need to be 
ingested (50 000 IU per day). There is also a large margin of safety as 10 000 IU of 
vitamin D daily for five months was studied and found not to cause toxicity. (1) 
Excessive sun exposure cannot result in toxicity as a plateau in vitamin D levels is 
reached after about 15 minutes of exposure. Thereafter there is photo-degradation of
vitamin D into inactive components, but not degradation of already synthesized 
vitamin D. (56)
A review by Cranney et al. (57) and a study by Aloia et al. (58) support the 
presumption that 25(OH) D levels increase with increased vitamin D intake. The 
relationship is however non-linear, possibly due to the number of factors that affect 
serum levels. 
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Calcium intake below the RDA for 19 to 50 year olds (1000 mg/day) (6) will result in 
increased 25(OH)D conversion to 1,25-hydroxyvitamin D, thus resulting in lower 
25(OH)D levels. Insufficient calcium intake is also a known cause of rickets. (42)
2.4.2 Sun exposure
Factors affecting serum 25(OH)D levels include geographical location (latitude and 
altitude), season, clothing, time of exposure, sunscreen use and skin pigmentation.
Holick et al. (9), reported that at latitudes above 37°N and below 37°S, the UVB rays 
are insufficient to induce adequate vitamin D3  production during winter months. The 
reason for this is the increased distance that UVB rays must travel through the ozone
layer due to the oblique angle of the rays at high or low latitudes. This is known as 
the Zenith angle. (3) Inadequate vitamin D levels have been found to be present 
even when sun exposure is plentiful, as in Honolulu, Hawaii (latitude 21°N). Mean 
25(OH)D levels in this study were not in the deficient range by current definitions, 
however they did border on insufficient (18). 
An in vitro vitamin D formation study in Johannesburg (26°S) and Cape Town (35°S),
revealed that in Cape Town very little vitamin D3 production took place during winter. 
In contrast the vitamin D3 formation in Johannesburg showed very little seasonal 
variation. These differences were presumed to be latitude related. (19) Other 
geographical factors increasing UVB radiation penetration are high altitude, minimal 
ozone or cloud cover and low pollution levels (3).
Seasonal variation in Australia’s sun exposure has been reported to result in a 63% 
increase in vitamin D levels from winter to summer (39). The reasons for these 
variations extend beyond the amount of daylight hours. Season affects climate and 
this in turn influences behaviour, such as the amount of clothing, sunscreen use or 
time spent in the sun.
Cultural clothing practices range from religious attire leaving minimal skin exposed, 
to cultural practices whereby actual “sun-bathing” takes place (41). The time of day 
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also influences UVB radiation exposure, with maximal exposure between 10:00 and 
15:00, but this too has considerable seasonal variation (3).
Sunscreens absorb UVB photons, reducing vitamin D synthesis by as much as 92 to 
95% in the case of Factor eight sunscreen (3). Melanin does the same, hence 
increased skin pigmentation significantly decreases vitamin D levels (4). 
The UV “index” was devised by the World Health Organization and World 
Meteorological Organization in 1994 as a standard indicator of UV levels. There are 
numerous factors influencing the UV Index. These are ozone, sun elevation, cloud 
cover, reflection by snow and pollution. (59) The UV Index is a linear scale. The 
higher the number, the greater the risk of radiation exposure due to UV rays. A UV 
index of zero corresponds to no UV radiation, for example, at night.  A UV index 
above 10 is common in the tropics, mountainous altitudes, and regions with 
significant ozone layer depletion (60) 
Skin cancers as a result of sun exposure
In a review by MacKie (61) it is stated that there is clear, strong evidence from 
epidemiological and animal studies that excessive exposure to UV radiation is a 
major cause of squamous cell carcinoma. Epidemiological studies also confirm that 
UV radiation is a major cause of basal cell carcinoma and three varieties of 
malignant melanoma. (61)
Thus, excessive sun exposure, particularly to the extent of burning in childhood, 
must be avoided. Sunscreens and protective clothing are essential during midday 
hours at most latitudes during summer. Mild sun exposure of 0.5 to 1 MED, three 
times a week, however, is still regarded as essential. (62)
2.4.3  Inadequate cutaneous synthesis, absorption and metabolism
As discussed under physiology, cutaneous vitamin D synthesis is dependent on 7-
dehydrocholesterol in the skin. With increasing age there is a decrease in 7-
dehydrocholesterol content in the skin, thus decreasing cutaneous vitamin D 
synthesis. (1, 3)
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In a study of obese individuals it was found that increased BMI resulted in a 
decreased bioavailablity of vitamin D from cutaneous synthesis. There was no 
difference in skin levels of 7-dehydrocholesterol, but instead inadequate release of 
vitamin D3 from the skin into circulation. This resulted in a 57% decrease in serum 
25(OH)D levels compared to non-obese individuals. Orally supplemented vitamin D 
did not show differences in bioavailability. (63)
As a result of vitamin D’s fat solubility, fat malabsorptive syndromes, bile acid or 
pancreatic lipase deficiencies can all negatively influence its absorption and hence 
25(OH)D levels. (9) There are also numerous chronic diseases known to interfere 
with vitamin D absorption (e.g. coeliac disease, irritable bowel syndrome and 
inflammatory bowel diseases).
With regard to medications, bile acid sequestrants (eg: cholestyramine), or enzyme 
inducers (anticonvulsants, rifampicin, protease inhibitors) may influence 25(OH)D 
levels, by retarding absorption or increasing metabolism. (9)
2.5 Laboratory testing of 25(OH)D
Laboratory measures of vitamin D consist of vitamin D2 [25(OH)D2] and vitamin D3 
[25(OH)D3] Active vitamin D, calcitriol, can also be measured. In the USA, vitamin D 
assays measure the combination of 25(OH)D2 and 25(OH)D3 to obtain a total 
25(OH)D. Traditionally, in Europe, only vitamin D3  has been measured. (6) 
Internationally several assay types are currently in use. In their review of vitamin D 
status in Africa, Prentice et al. (41) reported that 15 different assays were used 
across studies.
The two most common types of assays are:
• antibody-based methods
• liquid chromatography-based methods, which use automated equipment featuring 
either UV or mass spectrometric detection.
These methods are considered equivalent in terms of measuring a total 25(OH)D 
level in serum, but there is some controversy with regard to the performance of these
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assays in clinical and research laboratories. When interpreting the literature, it is 
important to be aware of the numerous assays available, and that serum 25(OH)D 
levels should be interpreted with care. (6) 
In this study High Performance Liquid Chromatography (HPLC), using UV-detection 
was used by the NHLS. Lensmeyer et al. (64) compared HPLC to the liquid 
chromatography–tandem mass spectrometry method, a competitive protein-binding 
assay and a radioimmune assay. They found the HPLC method to be reliable and 
robust which has an advantage over antibody based assays, since it is able to 
distinguish 25(OH)D2 and 25(OH)D3. (64)
2.6 Health consequences of vitamin D deficiency
2.6.1 Musculo-skeletal effects
Severe, chronic 25(OH)D deficiency in infants and children results in rickets. Rickets 
causes bone deformation. Interference with chondrocyte maturation results in 
inadequate mineralization of the epiphyses (due to inadequate calcium-phosphorous
product). This is as a result of the secondary hyperparathyroidism which results from
vitamin D deficiency. The hypocalcaemia also causes further renal loss of phosphate
and hypophosphataemia. This results in widening of the epiphyses of long bones, 
resulting in classical bowing. It also causes the rachitic rosary of the ribs, because of 
the costochondral junction bulging. Milder deficiencies may not result in rickets, but 
may hinder adolescents from attaining their peak bone mass. (25, 65)
Adults who are vitamin D deficient, already have fusion of their growth plates. The 
secondary hyperparathyroidism that results from this deficiency increases 
osteoclastic activity in bones to mobilise calcium and phosphorous to the 
extracellular space. This results in porous bones with insufficient mineralisation, 
resulting in decreased bone mineral density and an increase in fragility-fracture risk. 
(9, 24) Osteomalacia and osteoporosis are both metabolic bone diseases in adults. 
The differentiation is normally a histological one, however, the presence of bone pain
in osteomalacia has been found to be a common distinguishing feature (66). It has 
been suggested that when 25(OH)D levels are less than 10 ng/ml (25 nmol/l), 
osteomalacia is usually present (9).
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Vitamin D’s role in skeletal muscle function is explained by the presence of 
numerous calcitriol receptors within the muscle (65). Vitamin D deficiency is 
commonly associated with muscle weakness amongst children with rickets and 
adults with osteomalacia (67). A randomised control trial by Bischoff et al. (68) on 
treatment of the elderly with vitamin D and calcium versus calcium alone resulted in 
a 49% reduction in falls. 
2.6.2 Non calcium-related health consequences 
Breast, brain, colon, lung, skin, prostate and a multitude of other organs and tissues 
have been shown to express VDRs (69). In addition T and B lymphocytes and 
activated macrophages have also been shown to express VDR, revealing its role in 
immunity (70). It is difficult however, to supplement vitamin D for any condition other 
than osteoporosis, rickets or osteomalacia, as hypercalcaemia can result.
Cancer
Vitamin D’s role in cancer was initially observed in people living at higher latitudes in 
the USA. (71) They were found to have increased risk for Hodgkin’s lymphoma, in 
addition to colon, pancreas, ovarian and breast cancers in comparison to people 
living at lower latitudes (1, 9, 70). Latitude, however, is not always linearly-related to 
vitamin D levels (18). This is likely due to the great heterogeneity of factors 
influencing vitamin D levels.
Vitamin D has been found to exert a potent hormonal influence to regulate cell 
growth. Calcitriol induces differentiation into normally functioning cells and inhibits 
proliferation.(71) Much of the evidence for this, however, was obtained from in vitro 
studies. Despite this, evidence does exist to support the association between 
increased sun exposure and a lower incidence of many cancers (9). Holick (9), 
concedes that the level of evidence for this, is at times weak and is based on 
ecological cancer incidence studies. The IOM (6) corroborates this sentiment in their 
concluding statement on the association of vitamin D deficiency and cancers, where 
they state that “available evidence from randomised control trials and observational 
association studies for a relationship between vitamin D and/or calcium and the risk 
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for either incidence of or mortality from all cancers does not support the use of 
cancer mortality as an indicator for Dietary Reference Intake development.” (6) 
Autoimmune diseases, osteoarthritis and diabetes 
Vitamin D deficiency has been found to be associated with numerous autoimmune 
diseases (72). Amongst these are multiple sclerosis and inflammatory bowel 
disease. They occur because of an inappropriate immune-mediated attack against 
native tissue. Similar associations have been found with other autoimmune 
conditions like rheumatoid arthritis. Although non-immune related, osteoarthritis also 
has a similar association. As in the case of vitamin D’s relation to increased cancer 
incidence, a higher incidence of type 1-diabetes, multiple sclerosis, and inflammatory
bowel disease was initially discovered because of its association with people living at
higher latitudes. (72, 73) 
Pancreatic β cells possess VDRs and in response to calcitriol stimulation, increase 
insulin production (74). As discussed, vitamin D plays a role as an immune 
modulator and through this mechanism can possibly prevent autoimmune pancreatic
β cell destruction and thus the development of type I diabetes (9). This was 
illustrated by a birth-cohort study by Hyppönen et al. (75), which included 10,366 
Finnish children. Higher vitamin D supplementation (2000 IU daily) during the first 
year of life had a rate ratio of 0.22 (range, 0.05-0.89) of risk for type I diabetes 
compared to those who supplemented less vitamin D. 
Cardiovascular diseases
The evidence for the association of cardiovascular diseases with vitamin D stems 
from data in patients with end-stage renal disease. Early in chronic kidney disease, 
secondary hyperparathyroidism ensues as a result of the decreased activation of 
25(OH)D by the kidney. It is the elevated PTH that is the risk factor in the 
development of cardiovascular disease (76). Excess PTH increases blood pressure, 
cardiac contractility and also leads to cardiomyocyte hypertrophy and interstitial 
fibrosis of the heart (77). There are two hypotheses regarding the pathophysiology of
vitamin D deficiency leading to hypertension. The first is that hypocalcaemia and 
elevated PTH could be contributing factors to the hypertension. The second is that 
25
the vitamin D deficiency could result in an activation of the rennin-angiotensin 
system (76).
In addition to reduced insulin secretion, vitamin D deficiency can also result in insulin
resistance and contribute to “Syndrome X”. (78). Krause et al. (79) exposed 
hypertensive patients to UVB radiation three times a week and showed that the 
increase in vitamin D levels to above 100 nmol/l was associated with a significant 
decrease in their blood pressures (both systolic and diastolic pressure were reduced 
by 6 mmHg). Outdoor exercise may very well be the panacea to “Syndrome X”, 
targeting numerous aspects of the pathology: BMI, vitamin D, blood pressure and 
insulin resistance. (79)
Mental illness
Vitamin D’s association with mental illness goes beyond the logical link between 
sunshine and seasonal affective disorder (80). McGrath et al. (81) reported that there
is robust epidemiological data describing the relative excess of schizophrenia births 
in winter and spring. This is thought to be an indicator of sun exposure during the 
ante/ perinatal period. (81) In the study by McGrath et al. (81), an association 
between long term trends in sunshine duration around the time of birth and 
schizophrenia birth rates was found. This was, however, only statistically significant 
for males, a fact that could be due to the male preponderance in schizophrenia (82). 
It also brings into question whether ecological studies of this nature, truly reflect an 
association. 
Summary
This chapter addressed the physiology of vitamin D. It then explored the 
epidemiology of vitamin D deficiency, the factors influencing vitamin D levels, the 
laboratory testing of vitamin D and then discussed the health consequences of 
vitamin D deficiency.
In Chapter 3 methodology will be discussed.
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Chapter 3 Research Methodology
3.1  Introduction
In this chapter the problem statement, aims and objectives are presented. 
Furthermore, the ethical considerations, detailed research methodology, validity and 
reliability are explained.
3.2 Problem statement
Anaesthetists are indoors for most of their working hours and thus are at risk for 
vitamin D deficiency. Vitamin D is critical for calcium homeostasis and deficiency will 
hinder one’s attainment of peak bone mass (1). The other effects of vitamin D 
deficiency are less obvious, but still widespread in physiology, affecting immunity (7, 
8), increasing risk of certain cancers, autoimmune conditions, cardiovascular disease
and mental illness (1, 9).
Vitamin D deficiency is a global problem (1, 10, 17) that has been studied 
extensively in colder climates (9, 12, 13) and even been found in warmer climates 
(14, 15, 18). No research was identified among medical personnel in South Africa.  In
the Department of Anaesthesiology, University of the Witwatersrand (Wits), 
anaesthetists work on average 48 hours a week.  All of these hours are spent 
indoors and even though some are evening shifts, many daytime hours are spent 
doing preoperative visits, attending tutorials or studying.  For these reasons the 
study population is at risk for vitamin D deficiency, despite South Africa commonly 
being thought of as a land of sunshine (19). 
3.3 Aim and objectives
Aim
The aim of this was study to describe serum 25-hydroxyvitamin D [25(OH)D] levels 
during winter (mid-July to mid- August 2013), in anaesthetists working in the 
Department of Anaesthesiology, Wits.
Objectives
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The primary objective of this study was to describe serum 25(OH)D levels of 
anaesthetists.
The secondary objective was to describe and compare factors influencing vitamin D 
levels in anaesthetists who are vitamin D insufficient to those who are not. These 
factors included:
 ethnicity
 gender
 BMI
 multivitamin use
 calcium or vitamin D supplementation 
 sun exposure
 vitamin D intake from diet alone
 vitamin D intake from diet and supplementation
 calcium intake (dairy).
Using the questionnaire in Appendix 4, sun exposure was quantified into adequate or
inadequate for cutaneous vitamin D production. Anaesthetists were required to recall
average sun exposure over the past month. This was then quantified in comparison 
to an MED into an adequate (more than 30 minutes a week) or inadequate (less than
30 minutes a week) category.
3.4 Ethical considerations
This study was approved by the Human Research Ethics Committee (Medical) 
(Appendix 9) and the Postgraduate Committee, Health Sciences of Wits (Appendix 
10).
Approval for the study was obtained from the Chief Executive Officers of the 
following hospitals: CMJAH (Appendix 5), HJH (Appendix 7), RMMCH (Appendix 8) 
and the Medical Advisory Committee of CHBAH (Appendix 6).
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Invited participants were given an information sheet (Appendix 1) and if they agreed 
to participate, written informed consent was obtained (Appendix 2). All the 
information in the survey was kept confidential. A separate ‘Study number allocation 
sheet’ (Appendix 3) contained study number, participants’ names and contact details.
This sheet was kept confidential and was only accessed by the researcher and his 
supervisors. After completion of the study, the researcher contacted participants with 
their 25(OH)D results, if they requested them on their questionnaire (Appendix 4). 
Provision was made for a dietician to be consulted by anaesthetists, if they so 
wished.
Data would be stored securely for six years following completion of the study.
The study was conducted in adherence with the principles of the Declaration of 
Helsinki (21) and the South African Good Clinical Practice Guidelines and Good 
Laboratory Practice Guideline (22).
3.5 Research methodology
3.5.1 Research design
Research design may be described as the blueprint for a study (83). The methods 
which the researcher uses to obtain subjects, interpret results, collect and analyse 
data are all determined by the research design (84).
This study used a prospective, contextual, descriptive research design.
Brink (84) defines a prospective study as one in which the researcher follows a 
selected population over time to determine outcomes (84). This study was 
prospective because the variables were measured at the time the study took place.
De Vos (85) describes context as a “small-scale world” which, amongst other things, 
can include clinics, wards or critical care units. This study was contextual because it 
was conducted in the Departments of Anaesthesiology at the following hospitals: 
CMJAH, CHBAH and HJH and RMMCH.
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A descriptive study is one which is used when more information is required in a 
particular field, and involves identifying the characteristics of the observed 
phenomenon (86). This study was descriptive because it described anaesthetists’ 
vitamin D levels.
3.5.2 Study population
The study population was anaesthetists working in the Department of 
Anaesthesiology at Wits. 
3.5.3 Study sample
Sample size
In studies amongst medical personnel, the prevalence of vitamin D insufficiency is 
between 25 and 47%, with sample sizes ranging from 35 to 142 participants (12, 13, 
20).
In consultation with a biostatistician it was calculated with nQuery Advisor® version 7 
that a sample of at least 81 anaesthetists would estimate the expected proportion of 
insufficiency of 30% to an accuracy of within 10%. A slightly larger sample size to 
provide for laboratory error will be acceptable.
Sampling method
The sampling method is the process followed by the researcher to select a subset 
from the population to participate in a study (83, 84). Generally the population is too 
large to study in its entirety, thus the researcher works with samples (84).
Convenience sampling is referred to by Brink (84) as “accidental” or “availability 
sampling”. It entails the choosing of subjects who are readily available, as the 
objects for the study. This continues until the desired sample size is reached. (83, 
84) The disadvantage of this sampling method is that data might not truly represent 
the population.
A convenience sampling method was used for this study as available anaesthetists 
were enrolled until the sample size was realised.
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Inclusion and exclusion criteria
Inclusion criteria for this study were:
 anaesthetists working in the Department of Anaesthesiology.
 consenting to take part in the study.
Exclusion criteria for this study included:
 pregnancy
 known disorders of PTH
 renal disorders
 medication that interferes with vitamin D absorption or metabolism 
(anticonvulsants, glucocorticoids, ketoconazole, certain anti-retrovirals)
 diseases known to interfere with vitamin D absorption (eg: coeliac disease, 
irritable bowel syndrome and inflammatory bowel diseases)
 travel to a sun-rich destination within the month prior to the study
 anaesthetists who joined the department in the month prior to specimen 
collection.
3.5.4 Data collection
Data was collected over a period of one month, in winter (mid-July to mid-August 
2013).
The researcher e-mailed anaesthetists and gave a brief overview of the study and 
invited them to participate. The e-mail also included the information letter (Appendix 
1), and dates that sampling would take place at the various hospitals. Posters were 
displayed in the tearooms of the departments, reminding the anaesthetists about the 
study. A reminder e-mail was also sent the night before the sampling day.
On the morning of sample collection, anaesthetists agreeing to participate signed the
informed consent (Appendix 2), prior to enrolment in the study. The anaesthetists 
then completed the questionnaire (Appendix 4). The following data was obtained 
from the questionnaire:
 age
 gender
 ethnic group
 dietary supplementation 
 sun exposure
 sunscreen use
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 BMI
 diet
Furthermore, the anaesthetists were asked to indicate whether they would like to be 
informed of their results.
Specimen taking
Each participant had 5 ml of blood collected in a standardised manner into a purple 
top ethylenediaminetetraacetic acid blood specimen tube. 
The standardised manner was as follows.
 The researcher washed hands and donned gloves.
 A tourniquet was applied to the upper arm.
 The blood drawing site was cleaned with a 70% isopropyl alcohol swab and 
allowed to dry.
 A 20 or 22 gauge Vacutainer® needle and Vacutainer® needle holder was used
to withdraw 5 ml of blood into a purple top blood specimen tube.
 The blood specimen tube was then gently rotated for 30 seconds to ensure 
mixing of the blood with the ethylenediaminetetraacetic acid.
Specimen labelling
After filling the blood specimen tube with blood, a standard National Health 
Laboratory Service investigation request form was completed for every sample. 
Special attention was given not to use any participant information. 
The information was recorded as follows.
 Patient hospital number: Study number was written as “VITD-01”. Where 
“VITD” was a designation for this study in particular. “01” referred to a unique 
number that was assigned to every study participant, running consecutively 
from “01”.
 Surname: Research
 First name: Dr. E. Kelly
 Hospital: CMJAH, CHBAH,  HJH, RMMCH
 Ward: Theatre
 Diagnosis/ Reason for request: Research
 Type of specimen: Blood
 Date taken: dd-mm-yyyy
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 Time: hh:mm
 Taken by: Dr. E. Kelly
 Requesting health care worker: Dr. E. Kelly
 HPCSA/ SANC number: MP0658847
 Contact number: 074 116 5133
 E-mail address: eugene.h.kelly@gmail.com
 Investigation required: 25-hydroxyvitamin D
The unique study number was written on the blood specimen tube as well as on the 
questionnaire form.
A separate ‘Study number allocation sheet’ (Appendix 3) contained study number 
allocation, participants’ names and contact details. This sheet was kept separate 
from the raw data and would only be accessed by the researcher when the 
participants requested their results. 
Specimen storage and transport
Specimens were delivered to the Chemical Pathology Laboratory, Department of 
Chemical Pathology at Wits as soon as it was possible, by the researcher.
If there was a delay in transporting the specimens to the laboratory and testing was 
not done within eight hours, the specimens were refrigerated in a portable cooler at 2
to 8 ˚C. Samples were centrifuged and separated immediately by laboratory 
personnel. Samples are stable for four days at 4 ˚C. If processing could not take 
place within this time, samples were centrifuged and frozen. A frozen aliquot of 
serum remains stable at -20 ˚C for up to four weeks.
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Specimen processing
The processing of samples was done by qualified laboratory personnel, using 
standard chemical pathology equipment and procedures.  HPLC was performed to 
determine 25(OH)D levels using a Shimadzu® Nexera X2 Ultra performance liquid 
chromatography system with a photodiode array detector (Shimadzu®, Japan). The 
samples were extracted and analysed as per the “25 OH Vitamin D Recipe® kit” 
(Recipe® Munich, Germany) method where the vitamin D2 and D3 fractions of 
25(OH)D are separated and then combined to give total 25(OH)D. 50 ul of the 
extracted sample was injected onto the chromatographic system where the vitamin D
fractions were detected at 264nm. A three point calibration curve was run with every 
sample and two controls (one low level and one high level) were run every ten 
samples. 
The system was validated prior to running the sample with correlation coefficients 
r2=92% for linearity. The limit of detection was 1.2 nmol/l for 25(OH)D3 and 1.8 nmol/l
for 25(OH)D2. The limit of quantitation was 7 nmol/l for 25(OH)D3 and 9 nmol/l for 
25(OH)D2. Intraday and interday precisions were reported as 7% and 9% for 
25(OH)D3 and 6.5% and 8% for 25(OH)D2 .
3.5.5 Data analysis
Data was captured on Microsoft Office Excel 2010® spread sheets. The data was 
analysed using Statistica® Version 12.5. Data was then analysed using descriptive 
and inferential statistics.
The proportion of vitamin D insufficient anaesthetists was determined. 25(OH)D 
levels were described, using frequency, median and interquartile range. To achieve 
secondary objectives, factors influencing vitamin D levels in anaesthetists were 
compared using Chi-squared tests.
3.6 Validity and reliability of the study
Validity is defined by Burns and Grove (83) as “a measure of the truth or accuracy of 
a claim.” 
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According to Bothma et al.. reliability “represents the consistency of the measure 
achieved” (87).
Validity and reliability of this study were ensured by the following.
 A representative sample, as the study population and sample were close to 
the same size.
 Selection bias was minimized by approaching all anaesthetists in the 
department.
 The researcher collected, labelled, stored and transported all the samples in a
standardised manner.
 The processing of samples was done by qualified laboratory personnel using 
standard chemical pathology equipment and procedures.
The Shimadzu® HPLC machine was calibrated according to manufacturer’s 
recommendations. 
All data entry points in Microsoft Office Excel 2010® were checked for accuracy.
3.7 Summary
In this chapter the problem statement, aims and objectives were discussed. 
Furthermore, the ethical considerations, detailed research methodology, validity and 
reliability were explained. Chapter 4 will now discuss results.
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Chapter 4 Results and discussion 
4.1 Introduction 
This chapter contains the results and discussion thereof. Results are presented as 
per the research objectives.
The primary objective of this study was to describe serum 25(OH)D of anaesthetists.
The secondary objective was to describe and compare factors influencing vitamin D 
levels in anaesthetists who are vitamin D insufficient to those who are not. These 
factors included:
 ethnicity
 gender
 BMI
 multivitamin use
 calcium or vitamin D supplementation 
 sun exposure
 vitamin D intake from diet alone
 vitamin D intake from diet and supplementation
 calcium intake (dairy).
4.2 Results 
During the one month data collection period (mid-July to mid-August 2013), 92 
anaesthetists working in the Department of Anaesthesiology at Wits 
had blood samples taken and tested by HPLC to determine 25(OH)D levels.  
Of the 92 anaesthetists that were tested, 3 were excluded owing to laboratory error 
resulting in a total sample of 89 (n=89).
In the descriptive analysis, all 89 anaesthetists were used. For the tests of 
comparison, on the advice of the statistician, the “others” ethnic group was excluded 
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from the statistical analysis. The “others” ethnic group consisted of coloured, Asian 
and Arabic anaesthetists and had only eight anaesthetists in it.
In consultation with a biostatistician, a sample of at least 81 anaesthetists would 
estimate the expected proportion of insufficiency of 30% to an accuracy of within 
10%. %. A slightly larger sample size than was required was collected to provide for 
laboratory error.  The sample size was not calculated to adequately power the 
secondary objectives and thus, these should be interpreted with caution.
Defining categories
These are repeated here for continuity and ease of interpreting results.
According to the IOM, vitamin D status in free living healthy adults, with regard to 
bone health is defined as: 
 vitamin D deficiency: 25(OH)D <30 nmol/l (<12 ng/ml)(6)
 vitamin D inadequacy: 25(OH)D of 30 to 50 nmol/l (12 to 20 ng/ml)(6)
 vitamin D sufficiency: 25(OH)D of >50 nmol/l (>20 ng/ml)(6).
Most of the studies reviewed combine the vitamin D deficient and inadequate 
categories into one (12, 13, 15, 20). For this study this group will be called “vitamin D
insufficient”. 
4.2.1 Demographic characteristics of the study sample 
The study sample had a mean age of 31.33 years (± 4.32). Gender distribution, 
ethnicity and BMI are shown in Table 4.1.
37
Table 4.1 Demographic characteristics
Frequenc
y 
(%)
Gender    Female 45      (50.56)
Male 44      (49.44)
Ethnic 
Group
Black 20      (22.47)      
Indian 26      (29.21)      
White 35      (39.33)    
Arabic 4       (4.49)   
Asian 3       (3.37)     
Coloure
d
1       (1.12)     
BMI <25 55      (61.80)       
≥25 34      (38.20)    
4.2.2 Primary objective: Describe 25(OH)D of anaesthetists and describe the 
proportion anaesthetists who are vitamin D insufficient.
25(OH)D levels of anaesthetists were not normally distributed and thus the median is
reported. The median 25(OH)D is 43.8 nmol/l  (IQR 26-76).
Vitamin D status is further categorised in Table 4.2
Table 4.2 Vitamin D status
Vitamin D status Frequenc
y 
(%) Frequency     (%)
Deficient 28      (31.46)           
Insufficient 
51               (57.30)
Inadequate 23      (25.84)
Sufficient 38      (42.70)    
Table 4.2 reveals that there were 28 (31.46 %) anaesthetists who fell into the 
deficient category. Twenty three (25.84 %) were in the inadequate category. The 
combination of the deficient and inadequate categories into an insufficient category, 
as is common in the literature, reveals that 51 (57.30 %) anaesthetists were vitamin 
D insufficient.
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4.2.3 Secondary objectives
Describe and compare factors influencing vitamin D status in anaesthetists who are 
vitamin D insufficient to those who are sufficient. 
The following factors influencing vitamin D status are described and compared 
where appropriate:
 ethnicity
 gender
 BMI
 multivitamin use
 calcium or vitamin D supplementation 
 sun exposure
 vitamin D intake from diet alone
 vitamin D intake from diet and supplementation
 calcium intake (dairy)
4.2.3.1 Ethnicity
Description of vitamin D status
Vitamin D status according to the ethnicity of participants is shown in Table 4.3. 
Table 4.3 Vitamin D status according to ethnicity
Vitamin D 
status
Black Indian White Other Total
Insufficient
Frequency (%)
14 (70%) 21 (80.77%) 10 (28.57%) 3 (37.50%) 48
Sufficient
Frequency (%)
6 (30%) 5 (19.23%) 25 (71.43%) 5 (62.50%) 41
Median 
(IQR)
25(OH)D
41.85 nmol/l
(26.6-51.55)
23.05 nmol/l
(18.53-44.45)
73.2 nmol/l
(48.75-83.45)
37.00 nmol/l
(23.83-47.13)
Total 20 26 35 8 89
Comparison of Ethnicity and Vitamin D status
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The “others” ethnic group was excluded from the statistical analysis it had only eight 
participants.
A comparison between ethnicity and vitamin D status is illustrated in Table 4.4.
Table 4.4 Comparison of ethnicity and vitamin D status
Vitamin D 
status
Black
Frequency (%)
Indian
Frequency (%)
White
Frequency (%)
Total
Insufficient 14 (70%) 21 (80.77%) 10 (28.57%) 45
Sufficient 6 (30%) 5 (19.23%) 25 (71.43%) 36
Total 20 26 35 89
Chi2 [2] = 18.706, p < 0.001
There is a statistically significant association between ethnicity and vitamin D status 
(p<0.001).  Twenty one (80.77 %) Indian anaesthetists and 14 (70.00 %) black 
anaesthetists were insufficient, as compared to only 10 (28.57%) white 
anaesthetists.
4.2.3.2 Gender 
The vitamin D status as per gender and a comparison are illustrated in Table 4.5.
Table 4.5 Comparison of gender and vitamin D status
Vitamin D status Male
Frequency (%)
Female
Frequency (%)
Total
Insufficient 27 (33.3%) 24 (29.55%) 51
Sufficient 18 (40%) 20 (42.7%) 38
Total 45 44 89
Chi2[1]= 0.2705, p=0.60.
When gender and Vitamin D status were compared, there was no statistically 
significant association (p=0.60).
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4.2.3.3 BMI 
The description of BMI amongst the participants is illustrated in Table 4.6 
Table 4.6 BMI of study participants
BMI Frequency (%)
<25 55 61.8
≥25 34 38.2
Total 89 100
Comparison of BMI vitamin D status
When a comparison was made between the two groups of BMI <25 and BMI ≥25, 
using a Mann-Whitney test, the two-tailed P value was 0.6791. This is not considered
significant. Mann-Whitney U-statistic = 885.50 U' = 984.50.
Thus no significant difference between BMI with vitamin D status was found.
4.2.3.4 Multivitamin use
Multivitamin use is illustrated in Table 4.7
Table 4.7 Multivitamin use
Multivitamin use Frequency (%)
No 64 71.91
Yes 25 28.09
Total 89 100
Comparison between multivitamin use and vitamin D status 
A comparison between multivitamin use and vitamin D status is illustrated in table 
4.8.
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Table 4.8 Comparison between multivitamin use and vitamin D status
Vitamin D status No Multivitamin use
Frequency (%)
Multivitamin use
Frequency (%)
Total
Insufficient 42 (65.62%) 9 (36%) 51
Sufficient 22 (34.38%) 16 (64%) 38
Total 64 25 89
Chi2[1]=6.449, p=0.01
When a comparison was made between multivitamin use and vitamin D status, there
was found to be a statistically significant association (p=0.01).
Of the 25 anaesthetists using multivitamins, 16 (64%) were vitamin D sufficient, 
whereas only 9 (34%) were insufficient. This is in comparison to the anaesthetists 
not using multivitamins, where 42 (65.62%) were insufficient and 22 (34.38%) were 
sufficient.
4.2.3.5 Calcium or vitamin D supplementation
Calcium or vitamin D supplementation is illustrated in Table 4.9.
Table 4.9 Calcium or vitamin D supplementation
Calcium or vitamin D 
supplementation
Frequenc
y
(%)
No 85 95.51
Yes 4 4.49
Total 89 100
  
There were only four anaesthetists who took vitamin D or calcium supplementation. 
Three of them had sufficient vitamin D levels and one insufficient. Owing to the small 
numbers, no further analysis was done.
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4.2.3.6 Sun exposure 
Sun exposure amongst anaesthetists is illustrated in Table 4.10.
Table 4.10 Sun exposure amongst anaesthetists
Sun exposure Frequency (%)
Inadequate 66 74.16
Adequate 23 25.84
Total 89 100
Comparison between sun exposure and vitamin D status 
A comparison between sun exposure and vitamin D status is illustrated in Table 4.11.
Table 4.11 Comparison between sun exposure and vitamin D status
Vitamin D status Inadequate sun exposure
Frequency (%)
Adequate sun exposure
Frequency (%)
Total
Insufficient 38 (57.58 %) 13 (56.52 %) 51
Sufficient 28 (42.42 %) 10 (43.48 %) 38
Total 66 23 89
Chi2[1]=0.007745, p=0.93
No statistically significant association between sun exposure and vitamin D status 
could be found (p = 0.93).
4.2.3.7 Vitamin D intake from diet alone
Vitamin D intake was quantified into adequate or inadequate and illustrated in Table 
4.12.
Table 4.12 Vitamin D intake from diet alone
Vitamin D intake Frequency (%)
Inadequate 77 86.52
Adequate 12 13.48
Total 89 100
Comparison between vitamin D intake from diet alone and vitamin D status
A comparison between vitamin D intake from diet and vitamin D status is illustrated 
in Table 4.13.
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Table 4.13 Comparison between vitamin D intake from diet and vitamin D 
status
Status Inadequate intake
Frequency (%)
Adequate intake
Frequency (%)
Total
Not sufficient 47 (61.04%) 4 (33.33%) 51
Sufficient 30 (38.96%) 8 (66.67%) 38
Total 77 12 89
Chi2 [1]=3.257, p=0.07
No statistically significant association between dietary vitamin D intake and vitamin D
status was found (p= 0.07).
4.2.3.8 Vitamin D intake from diet and supplementation 
Vitamin D intake from diet and supplementation was quantified into adequate or 
inadequate and illustrated in Table 4.14.
Table 4.14 Vitamin D intake from diet and supplementation
Vitamin D intake Frequency Percent
Inadequate 57 64.04
Adequate 32 35.96
Total 89 100
Comparison between adequacy of vitamin D intake from diet and 
supplementation and vitamin D status
A comparison between vitamin D intake from diet and supplementation and vitamin 
D status is illustrated in Table 4.15.
44
Table 4.15 Comparison between vitamin D intake from diet and 
supplementation and vitamin D status
Vitamin D status Inadequate intake
Frequency (%)
Adequate intake
Frequency (%)
Total
Insufficient 37 (64.91%) 14 (43.75%) 51
Sufficient 20 (35.09%) 18 (56.25%) 38
Total 57 32 89
Chi2[1]=3.751, p=0.05
When a comparison was made between vitamin D intake from diet and 
supplementation and vitamin D status, the association was not found to be 
statistically significant (p=0.05).
4.2.3.9 Calcium intake from dairy products
Calcium intake predominantly from dairy was quantified into adequate or inadequate 
and illustrated in Table 4.16.
Table 4.16 Calcium intake from dairy products
Intake Frequency (%)
Inadequate 75 84.27
Adequate 14 15.73
Total 89 100
Comparison between vitamin D status of anaesthetists with regard to calcium 
intake 
A comparison between vitamin D status and calcium intake from dairy products is 
illustrated in Table 4.17.
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Table 4.17 Comparison between calcium intake and vitamin D status
Vitamin D status Inadequate dairy intake
Frequency (%)
Adequate dairy intake
Frequency (%)
Total
Insufficient 44 (58.67 %) 7 (50 %) 51
Sufficient 31 (41.33 %) 7 (50 %) 38
Total 75 14
Chi2 [1]=0.3622, p=0.55
When compared, no statistically significant association between calcium intake and 
vitamin D status was found (p=0.55).
4.3 Discussion 
The integral role Vitamin D plays in homeostasis spreads far beyond calcium and 
bone health (1, 2). In apparently “sunny”’ climates, the impact of inadequate sun 
exposure is often overlooked or under-investigated. The aim of this study was to 
describe the Vitamin D levels of anaesthetists working in the Department of 
Anaesthesiology.
The vitamin D levels of anaesthetists in our study were not normally distributed with 
a median 25(OH)D of 43.8 nmol/l  (IQR 26-76). Most of the studies reviewed had 
normally distributed 25(OH)D levels and thus reported mean 25(OH)D. In a normally 
distributed sample, the median is very close to the mean, so although a direct 
comparison between mean and median cannot be made, we are able to presume 
that our median 25(OH)D was generally lower than the median levels of 25(OH)D 
found in the majority of studies among doctors. The prevalence of vitamin D 
insufficiency in our study was found to be 57.3%.
Working indoors is known to be a risk factor for vitamin D insufficiency (10). Doctors 
also have increased risk due to long working hours. Studies among doctors like that 
of Growdon et al. (12) found 25% of trainee doctors to be insufficient. Haney et al. 
(13) found 47%, and Tangpricha et al. (20) found 30% to be insufficient.  All three of 
these studies were performed at northern latitudes during winter.
Mendoza et al. (15) found 75% of the doctors in their study, during the Mexican 
summer, to be insufficient. This is despite the fact that Mexico City had the highest 
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UV index figures of studies identified among doctors. Season and latitude alone 
cannot explain these high rates of insufficiency. Other factors influencing vitamin D 
levels need to be addressed. These include sun exposure, ethnicity, age, vitamin 
supplementation, diet, and BMI.
Growdon et al. (12) concluded from their study during Boston winter that despite 
their cohort not displaying traditional demographic characteristics associated with 
vitamin D deficiency, their residents had a very high prevalence of vitamin D 
insufficiency. Long working hours may have played a role here, as well as the fact 
that many residents and registrars spend much of their free time studying. Our study 
and that of Mendoza et al. (15) in Mexico expand on this. They reveal that not only 
indoor workers residing at higher altitudes are at risk, but also those from “sunny” 
climates. 
Our secondary objectives will now be discussed. This data should be interpreted with
caution as the sample size was not calculated to adequately power these objectives. 
Haney et al. (13) from their study in Portland Oregon found that sun exposure and 
multivitamin use were predictive of the 25(OH)D concentration. Sun exposure and 
multivitamin use were also considered as secondary objectives in our study. The 
former did not achieve statistical association with vitamin D status, but the latter did. 
The questionnaire that was used to determine this and other secondary objectives 
was based on literature review and discussion with a dietician and a vitamin D expert
(88). Quantification of sun exposure was based on the participants answering of the 
questionnaire (Appendix 4) which collated area of skin exposure and duration. This 
was then compared to the unit of comparison of UV radiation- an MED. Cultural attire
like “veiling”, was not specifically recorded in the questionnaire, but was incorporated
into the aforementioned quantification of sun exposure.
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Haney et al. (13) mentioned as a limitation to their study that they had a study 
sample that was predominantly Caucasian. In our study ethnicity was shown to be 
significantly associated with vitamin D status. The prevalence of insufficiency 
amongst Indian anaesthetists was 80.77%, as opposed to 70% of black 
anaesthetists and only 28.57% of white anaesthetists. This concurs with other 
studies that have shown darker skin pigmentation to be associated with lower 
25(OH)D levels (10, 89, 90). Additional reasons for varying levels of sun exposure 
include avoidance of the sun and cultural attire. A recent South African study by 
George et al. (51) mentioned diet, clothing and sun exposure all as compounding 
factors with regard to vitamin D levels.
Our study population was relatively homogenous with regard to age. The mean age 
was 31.33 (± 4.32) years. Advancing age’s effect on cutaneous vitamin D synthesis 
(1, 89) could not be shown. This makes the high prevalence of vitamin D 
insufficiency in our study striking, as advanced age has long been a recognised risk 
factor for poor vitamin D status (6).
Multivitamin use determined by the questionnaire (Appendix 4) revealed a significant
association with vitamin D levels. The questionnaire also determined dietary intake 
of vitamin D, aside from supplementation, to be quite poor. The reason for this could 
be that vitamin D rich foods are not commonly consumed by South Africans. (91) 
Additionally, staple food fortification is not practiced in South Africa, aggravating the 
poor dietary intake of vitamin D. 
Other physiological factors that are supposed to influence vitamin D levels negatively
like BMI (63) were not revealed by our study. The reason for this could be that with 
regard to BMI our study population was not normally distributed.
As an essential part of human physiology, vitamin D has long been overlooked. 
Northern latitude countries have begun to realise its importance, but owing to 
conventional risk stratification and a paradigm that “sunny” climates are exempt from
the problem, many individuals remain vitamin D insufficient.  As discussed 
extensively in the literature review, many individuals may be incorrectly classified as 
sufficient, because of the reference values being used by their medical advisors. The
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Endocrine Society defines sufficiency for individuals at risk for deficiency as >72.5 
nmol/l. The IOM defines sufficiency for free living healthy adults as >50nmol/l. From 
this it is clear that, although a prevalence of insufficiency of 57.3% amongst 
anaesthetists is quite high, this could be an underestimate, if anaesthetists were 
reclassified as a population at risk. 
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Chapter 5 Summary, limitations, recommendations and 
conclusion 
5.1 Introduction 
This chapter will summarise the aim, objectives, research methodology and results 
of this study. The limitations will be considered, recommendations made and a 
conclusion presented. 
5.2 Study summary 
5.2.1 Aim
The aim of this study was to determine 25(OH)D levels during winter (mid-July to 
mid- August 2013),  , in anaesthetists working in the Department of Anaesthesiology.
 
5.2.2 Objectives 
The primary objective of this study was to describe serum 25(OH)D of anaesthetists.
The secondary objective was to describe and compare factors influencing vitamin D 
levels in anaesthetists whoare vitamin D insufficient to those who are not. These 
factors included:
• ethnicity
• gender
• BMI
• multivitamin use
• calcium or vitamin D supplementation 
• sun exposure
• vitamin D intake from diet alone
• vitamin D intake from diet and supplementation
• calcium intake (dairy).
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5.2.3 Methodology 
This study used a prospective, contextual, descriptive research design.
Data was collected over a period of one month, in winter (mid-July to mid-August 
2013).
Anaesthetists agreeing to participate signed the informed consent (Appendix 2) prior 
to enrolment in the study. The anaesthetist then completed the questionnaire 
assessing factors influencing vitamin D levels (Appendix 4). 
Furthermore, the anaesthetists were asked to indicate whether they would like to be 
informed of their results. Each participant had 5 ml of blood collected in a 
standardised manner into a purple top ethylenediaminetetraacetic acid blood 
specimen tube. Specimens were delivered to the Chemical Pathology Laboratory, 
Wits Medical school campus, as soon as possible by the researcher. The processing
of samples was done by qualified laboratory personnel using standard chemical 
pathology equipment and procedures. HPLC was performed to determine 25(OH)D 
levels.
Data was analysed using descriptive and inferential statistics.
5.2.4 Main findings 
The median 25(OH)D was 43.8 nmol/l (IQR 26-76), with 51 of 89 (57.30 %) 
anaesthetists being vitamin D insufficient.
There was a statistically significant association between ethnicity and vitamin D 
status (p<0.001). Twenty one (80.77 %) Indian anaesthetists and 14 (70.00 %) black 
anaesthetists were insufficient, as compared to only 10 (28.57%) white 
anaesthetists.
There was no significant association between the other secondary objectives-
Gender (p=0.60), sun exposure (p = 0.93), Vitamin D intake from diet alone (p= 
0.07), vitamin D intake from diet and supplementation (p=0.05) and calcium intake 
(p=0.55) and vitamin D status.
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There was no significant difference between BMI and vitamin D status. When a 
comparison was made between the two groups of BMI <25 and BMI ≥25, using a 
Mann-Whitney test, the two-tailed P value was 0.6791. There was a significant 
association between multivitamin use (p=0.01) and vitamin D status.
5.3 Limitations 
This study was performed contextually within the Department of Anaesthesiology at 
Wits, therefore, the results may not be generalisable to any other anaesthesiology 
community.
The questionnaire that was used to determine demographic variables and other 
secondary objectives was based on literature review and discussion with a dietician 
and a vitamin D expert. (88) 
The secondary objectives should be interpreted with caution as the sample size was 
not calculated to adequately power these.
Owing to financial restraints PTH and calcium of subjects were not tested. Disorders 
of PTH, or hypo and hypercalcaemia may negatively or positively influence vitamin D
levels.
5.4 Recommendations 
5.4.1 Clinical practice 
Anaesthetists spend most of their day indoors. This is compounded by long working 
hours as well as the fact that many of them spend much of their free time studying. It
is thus recommended that anaesthetists spend more of their free time outdoors and 
that vitamin D supplementation should be taken, should levels be insufficient. 
Although sun exposure did not influence vitamin D levels in my study ( sun exposure 
was a secondary objective and thus possibly underpowered) it is known that 
exposure to sun increases vitamin D levels. A lecture to the Anaesthesiology 
Department will be held to highlight these concerns.
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5.4.2 Further research 
Further studies that are adequately powered for the variables included as secondary 
objectives in our study. These are ethnicity, gender, BMI, multivitamin use, calcium or
vitamin D supplementation, sun exposure, vitamin D intake from diet alone, vitamin 
D intake from diet and supplementation and calcium intake from dairy products. PTH
and calcium levels should also be tested when these studies are conducted.
5.5 Conclusion 
Vitamin D should no longer be a forgotten vitamin. The insufficient vitamin D levels of
anaesthetist in this study, puts them at risk for pathology far beyond bone health.  
Adequate vitamin D levels should be seen as essential, rather than optional, even in 
“sunny” climates. 
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Appendices
Appendix 1: Participants’ information letter
Dear colleague,
Hello, my name is Eugene Kelly and I am a registrar in the University of the 
Witwatersrand (Wits) Department of Anaesthesiology.
I would like you to invite you to participate in a research study: Vitamin D levels of 
anaesthetists in the Department of Anaesthesiology at the University of the 
Witwatersrand. This will be submitted to the Wits Faculty of Health Sciences towards
my MMed degree.
The primary objective of the study is to determine the proportion of anaesthetists that
have a vitamin D deficiency. A secondary objective is to describe and compare the 
factors influencing vitamin D levels amongst those that are deficient to those who are
not.
Vitamin D deficiency is a global health problem, with an estimated one billion people 
deficient worldwide. Deficiency has far reaching effects in normal physiology and 
pathophysiology. To name a few: interference with one’s attainment of peak bone 
mass, immune modulation, increased risk of certain cancers, autoimmune 
conditions, cardiovascular disease and mental illness.
I will also ask you to fill in a short questionnaire that will take less than 5 minutes to 
complete. The content of the questionnaires will only be viewed by me and my 
research supervisors. Your name will be kept on a separate data collection sheet, 
together with your phone number, so that you can be contacted with your results, 
should you request this.
After this 5 ml of blood will be collected and sent for serum 25-hydroxyvitamin D 
levels.
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Participation in this study is entirely voluntary. I will ask you to sign a consent form. 
You are free to withdraw from the study at any time, without having to provide a 
reason and there will be no repercussions. Published results will have no identifying 
data and will be made available to participants.
The study offers the following benefit to participants. Knowledge of ones vitamin D 
status allows supplementation or modification of factors influencing vitamin D levels. 
Should you wish to see a dietician, Lizl Veldsman (079 520 2568 ) will be available 
for consultation.
The study has been approved by the Human Research Ethics Committee (HREC) 
(Medical)  No.M130305 and the Postgraduate Committee of the University of the 
Witwatersrand.
Please ensure that you have read and understood all of the above information before
giving written informed consent.
Thank you for taking time to read this letter. If you have any questions or concerns 
with regard to the study, you may contact the following people with your queries:
 Professor Cleaton-Jones (chairperson of the HREC): (011)717-1234
 Eugene Kelly (researcher): 074 116 5133
Yours sincerely
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Eugene KellyAppendix 2: Informed consent
Research Title: Vitamin D levels of anaesthetists in the Department of 
Anaesthesiology at the University of Witwatersrand
I, ______________________________ understand what this study is about and 
consent to participate in the study. I have read and understand the participants’ 
information letter and my questions have been answered. I acknowledge the fact that
5 mls of blood will be drawn from me. I am aware that I may withdraw from the study 
at any time without any prejudice toward me. I understand that my name will not 
appear in any of the results of the research.
________________________ _____________
Signature of participant Date
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Appendix 3: Study Number Allocation Sheet
Study Number Name and telephone 
number
Want results
VTD-01
VTD-02
VTD-03
VTD-04
VTD-05
VTD-06
VTD-07
VTD-08
VTD-09
VTD-10
VTD-11
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Appendix 4: Questionnaire- Factors influencing vitamin D levels.
VTD-
_____________
Study Number
PLACE x OVER OPTION OR FILL IN IF APPLICABLE
1. Age (in years)
2. Gender Male Female
3. Ethnic group (white, black, indian, 
coloured, Asian).
4. Do you take a multivitamin? If yes 
state which
Yes
_________ No
5. Do you take calcium and vitamin D 
supplements? If yes state which
Yes
_________ No
6. Sun exposure: minutes of direct sun 
exposure to arms and legs between 
10:00 and 15:00.
> 30 min 
cumulatively /
week
< 30 min cumulatively / 
week
7. Sunscreen use Often Rarely
8. BMI
Height 
(metres)
Weight (Kilograms)
9. Dairy product consumption (total 
cumulative)- [milk in coffee = 50 ml; 1 
slice of cheese = 30mls]
> 750 ml 
daily
< 750 ml daily
10.Oily fish consumption (salmon, 
sardines, mackerel, tuna, cod liver oil) , 
shitake mushrooms
Daily (>4/5x 
a week)
Weekly 
(<2x a 
week)
Monthly/
rarely
11.Margarine consumption (Flora, 
Sunshine D- serving of one slice bread 
= 5g)
           
                ___________g daily
12.Egg yolks (number eaten weekly)
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13.Would you like your vitamin D 
results?
Yes No
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Appendix 5: CEO permission-CMJAH
70
Appendix 6: CHBAH permission from Medical Advisory Commitee
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Appendix 7: CEO permission-HJH
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Appendix 8: CEO permission-RMMCH
73
Appendix 9: Ethics clearance certificate
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Appendix 10: Postgraduate Committee approval
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